Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group.


Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
03 2023
Historique:
received: 02 08 2022
revised: 13 11 2022
accepted: 17 11 2022
pubmed: 23 12 2022
medline: 3 3 2023
entrez: 22 12 2022
Statut: ppublish

Résumé

Malignant pleural mesothelioma (MPM) is an aggressive primary malignancy of the pleura that presents unique radiologic challenges with regard to accurate and reproducible assessment of disease extent at staging and follow-up imaging. By optimizing and harmonizing technical approaches to imaging MPM, the best quality imaging can be achieved for individual patient care, clinical trials, and imaging research. This consensus statement represents agreement on harmonized, standard practices for routine multimodality imaging of MPM, including radiography, computed tomography,

Identifiants

pubmed: 36549385
pii: S1556-0864(22)01928-1
doi: 10.1016/j.jtho.2022.11.018
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

278-298

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Sharyn I Katz (SI)

Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: Sharyn.katz@pennmedicine.upenn.edu.

Christopher M Straus (CM)

Department of Radiology, University of Chicago Pritzker School of Medicine, Chicago, Illinois.

Leonid Roshkovan (L)

Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

Kevin G Blyth (KG)

Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.

Thomas Frauenfelder (T)

Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.

Ritu R Gill (RR)

Department of Radiology, Beth Israel Lahey Health, Harvard Medical School, Boston, Massachusetts.

Ferry Lalezari (F)

Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Jeremy Erasmus (J)

Department of Radiology, MD Anderson Cancer Center, Houston, Texas.

Anna K Nowak (AK)

Medical School, University of Western Australia, Perth, Australia.

Victor H Gerbaudo (VH)

Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Roslyn J Francis (RJ)

Medical School, University of Western Australia, Perth, Australia; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Australia.

Samuel G Armato (SG)

Department of Radiology, University of Chicago Pritzker School of Medicine, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH